Taiwan FDA registration b420913495ca2ed5853dd931114e83f7
"Safety Assessment" Mycobacterium tuberculosis antibody rapid test reagent (unsterilized)
TW: "安評" 結核桿菌抗體快速檢驗試劑 (未滅菌)
Taiwan·Risk Class 1·MP BIOMEDICALS ASIA PACIFIC PTE. LTD.·Registered Dec 18, 2012 – Dec 18, 2017CancelledRegistration details
- Analysis ID
- b420913495ca2ed5853dd931114e83f7
- Customs Code
- DHA04401250003
Company information
- Manufacturer
- MP BIOMEDICALS ASIA PACIFIC PTE. LTD.
- Manufacturer Country
- Singapore
- Authorized Representative
- JOLEX INTERNATIONAL CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of Mycobacterium tuberculosis immunofluorescent reagent (C.3370) of the management method for medical devices.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3370 結核桿菌免疫螢光試劑
- Import Information
- import
Dates and status
- Registration Date
- Dec 18, 2012
- Expiry Date
- Dec 18, 2017
- Cancellation Date
- Jan 19, 2019
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Safety Assessment" Mycobacterium tuberculosis antibody rapid test reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number b420913495ca2ed5853dd931114e83f7 and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is JOLEX INTERNATIONAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices